Campbell & Co Investment Adviser’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,122
| Closed | -$587K | – | 1058 |
|
|
2024
Q2 | $587K | Buy |
+36,122
| New | +$587K | 0.05% | 593 |
|
|
2024
Q1 | – | Sell |
-67,342
| Closed | -$2.11M | – | 1070 |
|
|
2023
Q4 | $2.11M | Buy |
+67,342
| New | +$2.11M | 0.19% | 119 |
|
|
2023
Q3 | – | Sell |
-15,619
| Closed | -$374K | – | 907 |
|
|
2023
Q2 | $374K | Buy |
+15,619
| New | +$374K | 0.07% | 566 |
|
|
2021
Q4 | – | Sell |
-15,250
| Closed | -$253K | – | 596 |
|
|
2021
Q3 | $253K | Buy |
+15,250
| New | +$253K | 0.08% | 434 |
|
|
2020
Q3 | – | Sell |
-4,581
| Closed | -$222K | – | 371 |
|
|
2020
Q2 | $222K | Buy |
+4,581
| New | +$222K | 0.28% | 185 |
|
|
2020
Q1 | – | Sell |
-5,040
| Closed | -$216K | – | 22 |
|
|
2019
Q4 | $216K | Sell |
5,040
-11,153
| -69% | -$478K | 0.07% | 558 |
|
|
2019
Q3 | $583K | Buy |
+16,193
| New | +$583K | 0.22% | 136 |
|
|
2017
Q3 | – | Sell |
-9,817
| Closed | -$274K | – | 337 |
|
|
2017
Q2 | $274K | Buy |
+9,817
| New | +$274K | 0.25% | 163 |
|